Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies

Piaopiao Zhang,1 Jie Wang,2 Hangbin Hu,1 Sheng Zhang,3 Juying Wei,4 Qing Yang,1 Tingting Qu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Res...

Full description

Bibliographic Details
Main Authors:	Zhang P, Wang J, Hu H, Zhang S, Wei J, Yang Q, Qu T
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-09-01
Series:	Infection and Drug Resistance
Subjects:	carbapenem-resistant klebsiella pneumoniae bloodstream infection hematologic malignancy risk factors prediction
Online Access:	https://www.dovepress.com/clinical-characteristics-and-risk-factors-for-bloodstream-infection-du-peer-reviewed-article-IDR

Similar Items

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
by: Meng H, et al.
Published: (2022-08-01)

A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection
by: Qian C, et al.
Published: (2023-01-01)

Risk factors and prognosis of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in ICU patients: a report of 81 cases
by: LIU Meng, XU Wen, DAI Yunqi, TAN Ruoming, LIU Jialin, GU Feifei, CHEN Erzhen, WANG Xiaoli, QU Hongping, QIU Yuzhen
Published: (2023-09-01)

Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies
by: Livio Pagano, et al.
Published: (2014-07-01)

Comparison of bloodstream and non-bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae in the intensive care unit: a 9-year respective study
by: Xiangyuan Sun, et al.
Published: (2023-09-01)

Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study
by: Cao Z, et al.
Published: (2022-02-01)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
by: Lu L, et al.
Published: (2022-06-01)

Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China
by: Liang X, et al.
Published: (2022-06-01)

Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China
by: Yuanyuan Li, et al.
Published: (2020-06-01)

Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
by: Lin Di, et al.
Published: (2018-10-01)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
by: Qiqiang Liang, et al.
Published: (2019-05-01)

Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study
by: Jie Chen, et al.
Published: (2022-12-01)

Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies
by: Yuan F, et al.
Published: (2023-07-01)

Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Tao Wang, et al.
Published: (2023-12-01)

Prevalence of Carbapenem-Resistant Klebsiella pneumoniae Co-Harboring blaKPC-Carrying Plasmid and pLVPK-Like Virulence Plasmid in Bloodstream Infections
by: Fang-ling Du, et al.
Published: (2021-03-01)

Detection of Carbapenem-Resistant Klebsiella pneumonia using two Sensitivity Methods
by: Ghusoon Ali Abdulhasan, et al.
Published: (2015-12-01)

Ceftazidime/Avibactam, Polymyxin or Tigecycline as a Rescue Strategy for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae in Bloodstream Infection: A Retrospective Cohort Study
by: Fang Y, et al.
Published: (2023-05-01)

Evaluation and Identification of Carbapenem Resistant Klebsiella pneumoniae Isolated from Hospitalized Patients in Qom City, (Iran)
by: Syed Soheil Aghaei, et al.
Published: (2019-06-01)

Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenem-resistant Klebsiella pneumoniae
by: I-Ren Chen, et al.
Published: (2021-06-01)

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options
by: Lining Zhang, et al.
Published: (2023-05-01)

Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
by: Dakang Hu, et al.
Published: (2022-06-01)

Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV- with high dose combination of imipenem and amikacin
by: Zied Hajjej, et al.
Published: (2016-01-01)

Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy
by: Daniela Loconsole, et al.
Published: (2020-06-01)

Development of a Risk Prediction Model of Subsequent Bloodstream Infection After Carbapenem-Resistant Enterobacteriaceae Isolated from Perianal Swabs in Hematological Patients
by: Liu J, et al.
Published: (2023-03-01)

Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
by: Lili Fang, et al.
Published: (2020-09-01)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
by: Feiyang Zhang, et al.
Published: (2021-12-01)

Evaluation of Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae Bacteremia
by: Pınar Kıran, et al.
Published: (2020-03-01)

Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012–2019
by: Meng Li, et al.
Published: (2022-03-01)

Risk Factors for Subsequential Carbapenem-Resistant Klebsiella pneumoniae Clinical Infection Among Rectal Carriers with Carbapenem-Resistant Klebsiella pneumoniae
by: Chen X, et al.
Published: (2020-05-01)

Screening of Carbapenem Resistance Klebsiella pneumoniae and its MIC against Imipenem
by: Sarada Saud, et al.
Published: (2022-07-01)

Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies
by: Rym Lalaoui, et al.
Published: (2020-07-01)

Molecular detection of carbapenem resistant Klebsiella pneumoniae isolated from clinical specimens in Jos, Nigeria
by: Jude Nkup, et al.
Published: (2023-05-01)

Risk model and validation of carbapenem-resistant Klebsiella pneumoniae infection in patients with cerebrovascular disease in the ICU
by: Liao Qiuxia, et al.
Published: (2023-08-01)

Gram-Negative Bacteria Bloodstream Infections in Patients with Hematological Malignancies – The Impact of Pathogen Type and Patterns of Antibiotic Resistance: A Retrospective Cohort Study
by: Tang Y, et al.
Published: (2021-08-01)

Carbapenem-Resistance in Clinical Klebsiella pneumoniae Isolates from Iran, Review Article
by: Mahboobe Moghadam, et al.
Published: (2021-12-01)

A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by Klebsiella pneumoniae
by: Chen Y, et al.
Published: (2022-03-01)

Factors Associated with Extended-Spectrum β-Lactamases and Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Bloodstream Infections: A Five-Year Retrospective Study
by: Andreas G. Tofarides, et al.
Published: (2023-10-01)

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01)

Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient
by: Wasim S. El Nekidy, et al.
Published: (2017-01-01)

AmpR Increases the Virulence of Carbapenem-Resistant Klebsiella pneumoniae by Regulating the Initial Step of Capsule Synthesis
by: Zhang M, et al.
Published: (2020-10-01)